Publications within 3 years of SGO annual meeting per funding type and study design between 2017 and 2018
| Podium presentations published within 3 years | |||
| 2017 | 2018 | 2017–2018 | |
| Funding subtypes | |||
| NIH | 15 (34.9%) | 14 (29.8%) | 29 (32.2%) |
| Non-NIH | 7 (16.2%) | 12 (25.5%) | 19 (21.1%) |
| None | 16 (38.1%) | 11 (23.4%) | 27 (30.0%) |
| Pharmaceutical | 5 (11.6%) | 10 (21.3%) | 15 (16.7%) |
| Study design subtypes | |||
| Experimental | 8 (18.6%) | 15 (31.9%) | 23 (25.6%) |
| Non-experiemental | 25 (58.1%) | 27 (57.3%) | 52 (83.3%) |
| Pre-clinical research | 10 (23.3%) | 5 (10.6%) | 15 (16.7%) |
| Total | 43 | 47 | 90 |
Table demonstrates the publication rates segregated by year and subdivided to include the following: funding and study design sub-types.
NIH, National Institutes for Health.